Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan + amlodipine vs irbesartan in mild to moderate hypertension uncontrolled on irbesartan
CTR20211191Phase 3Completed
- Sponsor
- Jiangxi Shimei Pharmaceutical
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irbesartan + amlodipine in essential hypertension, sponsored by Jiangxi Shimei Pharmaceutical. Started Jun 2021; status: completed.
02
Drugs
irbesartan + amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20211191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211191.